tradmap

IBO Earnings IMPACT BIOMEDICAL INC.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$2 -$1 $0 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $25000 $50000 2022 2023 2024 2025
Revenue
Net income (annual)
-$25M -$12M $0 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$1 -$1 $0 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Revenue (quarterly)
$0 $9000 $18000 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$27M -$11M $5M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–17 of 17
Q2 20262026-06-30-0.032026-08-0710-Q
Q1 20262026-03-31-0.022026-05-1210-Q
FY 20252025-12-31-0.382026-03-1110-K
Q3 20252025-09-30-1.412025-11-0710-Q
Q2 20262025-06-30-1.292026-08-0710-Q
Q1 20262025-03-31-0.112026-05-1210-Q
FY 20252024-12-31-2.302026-03-1110-K
Q3 20252024-09-300.032025-11-0710-Q
Q2 20252024-06-30-0.182025-08-1410-Q
Q1 20252024-03-31-0.102025-05-1410-Q
FY 20242023-12-31-0.072025-03-2810-K
Q3 20242023-09-30-0.042024-11-1210-Q
Q2 20242023-06-30-0.032024-08-1310-Q
Q1 20242023-03-31-0.012024-05-1010-Q
FY 20232022-12-31-0.102024-02-2010-K
Q3 20232022-09-30-0.062023-11-1310-Q
Q2 20232022-06-300.002023-10-0510-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.